These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 23830018

  • 21. Practice patterns and guideline adherence in the management of attention deficit/hyperactivity disorder.
    McElligott JT, Lemay JR, O'Brien ES, Roland VA, Basco WT, Roberts JR.
    Clin Pediatr (Phila); 2014 Sep; 53(10):960-6. PubMed ID: 24982441
    [Abstract] [Full Text] [Related]

  • 22. Prevalence, incidence and persistence of ADHD drug use in Japan.
    Okumura Y, Usami M, Okada T, Saito T, Negoro H, Tsujii N, Fujita J, Iida J.
    Epidemiol Psychiatr Sci; 2019 Dec; 28(6):692-696. PubMed ID: 29804548
    [No Abstract] [Full Text] [Related]

  • 23. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
    Blum NJ, Shults J, Harstad E, Wiley S, Augustyn M, Meinzen-Derr JK, Wolraich ML, Barbaresi WJ.
    J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
    [Abstract] [Full Text] [Related]

  • 24. [Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)].
    Käypä hoito suosituksen päivitystiivistelmä.
    Duodecim; 2012 Sep; 128(5):539-40. PubMed ID: 22486070
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants.
    Mittal S, Boan AD, Kral MC, Lally MD, van Bakergem K, Macias MM, LaRosa A.
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):81-86. PubMed ID: 31621385
    [Abstract] [Full Text] [Related]

  • 30. Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.
    Song I, Shin JY.
    Epidemiol Health; 2016 Mar; 38():e2016045. PubMed ID: 27866408
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N, Keim S, Adesman A.
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [Abstract] [Full Text] [Related]

  • 35. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM.
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Assessment and treatment of attention-deficit/hyperactivity disorder: part 2.
    French WP.
    Pediatr Ann; 2015 Apr; 44(4):160-8. PubMed ID: 25875981
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.